News for Healthier Living

Real-World Effectiveness and Safety of Janus Kinase 1 Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis: A Single-Center, Prospective Study in China

Researchers from Xiangya Hospital, Central South University, et al. have conducted a study entitled "Real-world effectiveness and safety of Janus kinase 1 inhibitors for the treatment of moderate-to-severe atopic dermatitis: a single-center, prospective study in China". This study was published in Frontiers of Medicine, Volume 18, Issue 4.

November 14, 2025


November 15 2025

November 14 2025

November 13 2025

November 12 2025

November 11 2025

November 10 2025

November 9 2025

November 8 2025

November 7 2025

November 6 2025

November 5 2025

November 4 2025

November 3 2025

November 2 2025

November 1 2025